ストックスクリーナーアプリを入手
1.045
2.80%
-0.025
前日終値:
$1.07
開ける：
$1.05
24時間の取引高:
450.02K
Relative Volume:
0.92
時価総額：
$36.53M
収益：
$3.25M
当期純損益:
$-116.80M
株価収益率:
-0.3885
EPS:
-2.69
ネットキャッシュフロー:
$-98.17M
1週間 パフォーマンス:
-18.75%
1か月 パフォーマンス:
-36.78%
6か月 パフォーマンス:
-77.34%
1年 パフォーマンス:
-92.36%
1日の値動き範囲:
$1.00
$1.07
1週間の範囲:
$1.00
$1.30
52週間の値動き範囲:
$1.00
$27.35
Rapt Therapeutics Inc Stock (RAPT) Company Profile
名前
Rapt Therapeutics Inc
セクター
電話
(650) 489-9000
住所
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
RAPT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| RAPT | 1.045 | 36.53M | 3.25M | -116.80M | -98.17M | -2.69 |
| VRTX | 449.81 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.30 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 595.77 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.16 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.17 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-14 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-05-10 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-02-22 | ダウングレード | UBS | Buy → Neutral |
| 2024-02-21 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-02-21 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | 開始されました | Evercore ISI | Outperform |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-09-14 | 開始されました | Berenberg | Buy |
| 2023-08-09 | 開始されました | Stifel | Buy |
| 2023-06-15 | 開始されました | Barclays | Overweight |
| 2023-01-04 | 開始されました | Guggenheim | Buy |
| 2022-12-01 | 開始されました | Goldman | Buy |
| 2022-09-21 | 開始されました | CapitalOne | Overweight |
| 2022-05-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-12-09 | 開始されました | JP Morgan | Overweight |
| 2021-08-12 | 開始されました | SVB Leerink | Outperform |
| 2021-06-21 | 開始されました | Piper Sandler | Overweight |
| 2020-06-01 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-04-13 | 開始されました | ROTH Capital | Buy |
| 2019-11-25 | 開始されました | BMO Capital Markets | Outperform |
| 2019-11-25 | 開始されました | UBS | Buy |
| 2019-11-25 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Rapt Therapeutics Inc (RAPT) 最新ニュース
RAPT scraps zelnecirnon program, stock plunges 46% (update) - MSN
RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull - MSN
RAPT Therapeutics stock plunges to 52-week low of $1.11 By Investing.com - Investing.com UK
RAPT Therapeutics announces option repricing to retain talent By Investing.com - Investing.com Nigeria
Leerink Partnrs Issues Optimistic Forecast for RAPT Earnings - MarketBeat
Leerink Partnrs Expects Lower Earnings for RAPT Therapeutics - MarketBeat
RAPT Therapeutics' SWOT analysis: biotech firm faces challenges, seeks new path - Investing.com Canada
RAPT Therapeutics Reports Improved Q3 2024 Results - TipRanks
RAPT Therapeutics' (RAPT) Hold Rating Reaffirmed at Stifel Nicolaus - MarketBeat
Wells Fargo & Company Has Lowered Expectations for RAPT Therapeutics (NASDAQ:RAPT) Stock Price - MarketBeat
RAPT Therapeutics (NASDAQ:RAPT) Earns "Neutral" Rating from HC Wainwright - MarketBeat
RAPT Therapeutics Reports Third Quarter 2024 Financial Results - GlobeNewswire
RAPT Therapeutics Narrows Q3 Loss by 41%, Cuts R&D Spend Amid Restructuring | RAPT Stock News - StockTitan
RAPT Therapeutics stock hits 52-week low at $1.49 By Investing.com - Investing.com Australia
RAPT Therapeutics Inc (RAPT) Quarterly 10-Q Report - Quartzy
RAPT Therapeutics stock hits 52-week low at $1.49 - Investing.com
Rapt Scraps Zelnecirnon, But Not Giving Up On CCR4 - Citeline News & Insights
Crude Oil Down 3%; Aramark Posts Upbeat Earnings - Benzinga
Nasdaq Moves Lower; Canaan Shares Surge - Benzinga
JPMorgan cuts Rapt Therapeutics to Underweight By Investing.com - Investing.com UK
JPMorgan Chase & Co. Downgrades RAPT Therapeutics (NASDAQ:RAPT) to Underweight - MarketBeat
U.S. Stock market: Binah Capital Group(+105.01%) and CERo Therapeutics(+152.00%) see strong gains, RAPT Therapeutics(−44.12%) declines during mid day trading - Business Upturn
Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury - Benzinga
U.S. Stock market: RAPT Therapeutics drops 41% while CERo Therapeutics surges 136% in early trading - Business Upturn
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results - Benzinga
Rapt Therapeutics Stops Development of Asthma, Atopic Dermatitis Drug Candidate After Reaction Sidelines Trials - MarketWatch
Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury - The Manila Times
Based on Recent FDA Feedback RAPT Therapeutics Stops - GlobeNewswire
RAPT Therapeutics Halts Key Drug Program After FDA Safety Concerns, Liver Injury | RAPT Stock News - StockTitan
Contrasting RAPT Therapeutics (NASDAQ:RAPT) and Elanco Animal Health (NYSE:ELAN) - Defense World
Can RAPT Therapeutics (NASDAQ:RAPT) Afford To Invest In Growth? - Simply Wall St
Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky - Yahoo Finance
Vanguard Group Inc's Strategic Acquisition in RAPT Therapeutics Inc - GuruFocus.com
Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings? - MSN
RAPT Therapeutics stock plunges to 52-week low of $1.65 By Investing.com - Investing.com Australia
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Average Rating of "Hold" by Analysts - MarketBeat
RAPT Therapeutics stock plunges to 52-week low of $1.65 - Investing.com
RAPT stock touches 52-week low at $1.72 amid sharp yearly decline - Investing.com
Point72 Asset Management L.P. Acquires 706,900 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - MarketBeat
RAPT Therapeutics Inc (RAPT) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Cubist Systematic Strategies LLC Increases Stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - MarketBeat
XTX Topco Ltd Invests $108,000 in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
RAPT Therapeutics' SWOT analysis: biotech stock faces clinical hurdles - Investing.com
RAPT Therapeutics, Inc. (RAPT): Worst 52-Week Low Stock to Buy Now - Yahoo Finance
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability - Insider Monkey
15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers - Insider Monkey
RAPT stock touches 52-week low at $1.76 amid sharp annual decline - Investing.com India
Daily Progress: RAPT Therapeutics Inc (RAPT) Drop -7.25, Closing at 1.79 - The Dwinnex
Federated Hermes Inc. Boosts Stock Holdings in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - MarketBeat
Acadian Asset Management LLC Raises Stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - MarketBeat
Rapt Therapeutics Inc (RAPT) 財務データ
収益
当期純利益
現金流量
EPS
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):